Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

E.U. label change for Intron

April 28, 2006

Phase I data presented on SLV-317

April 28, 2006

Recent patents report new treatments for gastrointestinal disorders

April 26, 2006

Amitiza now available for chronic idiopathic constipation

April 26, 2006

U.S. study of NOV-205 for hepatitis C cleared to begin

April 26, 2006

NDA submission planned for room-temperature formulation of MNTX

April 26, 2006

HCV levels reduced in nonresponders receiving HCV-I.E.T.

April 25, 2006

Feron approved in Japan for compensatory cirrhosis C

April 21, 2006

Schering-Plough updates status of phase II study of SCH-503034

April 21, 2006

Enrollment completed in Entereg phase III program

April 19, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....